Recently, an investigation with a large cohort of patients proposed that serum IL-6 and TNF levels should be considered in the management and treatment of patients with COVID-19 to stratify prospective clinical trials, guide resource allocation and inform therapeutic opportunities (17). Here, IL6 is linked to COVID-19.